Introduction

Oncology Reports

1021-335X 1791-2431

D.A. Spandidos

10.3892/or.2018.6377

or-39-06-2845

Articles

Spermidine-induced growth inhibition and apoptosis via autophagic activation in cervical cancer

Chen

1 * Zhuang

Haifeng

2 * Chen

Xuerui

3 Shi

Zheqi

3 Wang

1College of Laboratory Medicine, Hangzhou Medical College, Hangzhou, Zhejiang 310053, P.R. China 2The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, P.R. China 3Department of Chemistry, Zhejiang University, Hangzhou, Zhejiang 310027, P.R. China

Correspondence to: Professor Xu Wang, College of Laboratory Medicine, Hangzhou Medical College, 481 Binwen Road, Binjiang, Hangzhou, Zhejiang 310053, P.R. China, E-mail: wangxu@hmc.edu.cn *

Contributed equally

062018

18042018

39 6 2845 2854 13092017 13042018

2018

Cervical cancer is the most common malignancy of the female reproductive tract, and the poor response to prophylactic vaccines and the toxicity of high-dose chemotherapeutic drugs have limited their clinical application. Spermidine, a natural polyamine detected in all eukaryotic organisms, exhibits functions that promote longevity in multiple model systems and may constitute a promising agent for cancer treatment. However, the potential effectiveness of spermidine in cervical cancer has not yet been fully elucidated, and the underlying molecular mechanisms remain unclear. In the present study, we aimed to assess the effects of spermidine on proliferation and apoptosis of HeLa cells (a cervical cancer cell line). Firstly, CCK-8 and flow cytometric assays revealed that spermidine reduced the proliferation of HeLa cells in a dose-dependent fashion by arresting the cell cycle at the S phase. Secondly, flow cytometry incorporating Annexin V-FITC/PI-staining revealed that spermidine promoted the apoptosis of HeLa cells, and western blot analysis revealed that spermidine activated autophagy. Finally, spermidine-activated autophagy mediated the inhibition of cell proliferation by spermidine and spermidine-induced apoptosis in HeLa cells. Collectively, these results revealed a novel function for spermidine in inhibiting cellular proliferation and inducing apoptosis of HeLa cells by activating autophagy, which may have important implications for the use of spermidine in cervical cancer therapy.

spermidine cervical cancer proliferation apoptosis autophagy

Introduction

Cervical cancer is the most common malignancy of the female reproductive tract, and 95% of cases are caused by persistent infections with carcinogenic human papillomaviruses (HPV) (1). Cervical cancer accounts for 528,000 new cases and 266,000 deaths worldwide each year, more than any other gynecologic tumor (2). Effective preventive vaccines are available for the most important carcinogenic HPV strains, but their use remains poor (3). At present, the combination of radiotherapy and platinum-based chemotherapy is the gold-standard therapy for advanced cervical cancer (4). Although the addition of platinum-based chemotherapy to radiotherapy has increased the 5-year survival of advanced-stage cervical cancer patients (5), systemic toxicity limits the use of high-dose chemotherapeutic drugs. Therefore, new therapeutic strategies that are less toxic and that provide higher efficacy against cervical cancer are urgently needed. Natural components provide a great deal of opportunity for preventing or changing the pathogenic course of the disease in a safer and more cost-effective way.

Apoptosis and autophagy are both cellular degradative pathways essential for organismal homeostasis. Dysregulation of apoptosis leads to the accumulation of ‘unwanted’ cells and contributes to the development of cancer (6). Anticancer therapeutics may be used to promote apoptosis within cancer cells to cause the death of these cells. Current anticancer therapies, including many chemotherapeutic agents and ionizing radiation therapy, usually activate apoptosis and utilize the apoptotic machinery for killing cancer cells (7,8). Autophagy can remove damaged proteins and organelles, and it limits their cumulative deleterious effects intracellularly. Therefore, autophagic defects are found in many human tumors (9,10). In addition, excessive autophagy has been involved in autophagic cell death, which is characterized by morphological changes, such as the accumulation of autophagosomes in the cell (11). In contrast to the tumor-suppressor roles for autophagy, stress-activated autophagy may promote survival of tumor cells, especially when apoptosis is defective (6). Previous studies have suggested that fucoidan may exert its antiproliferative action in cultured HeLa cells by inducing apoptotic and autophagic cell death (12), and glaucocalyxin B may supress the proliferation of human cervical cancer cells in vitro through the induction of apoptosis and autophagy (13). Therefore, the study of the mechanisms underlying apoptosis and autophagy should provide therapeutic benefits in human cervical cancer.

Spermidine, a natural polyamine detected in all eukaryotic organisms, exhibits many biological functions. It is involved in processes such as cellular proliferation, differentiation, tissue development, and carcinogenesis (14). Recent studies have revealed that macrophage ABHD5 suppressed spermidine production and subsequently promoted colorectal cancer growth (15). In addition, oral spermidine suppressed liver fibrosis and hepatocellular carcinoma in mice by activating MAP1S-mediated autophagy (16). It is suggested that spermidine constitutes a promising agent for the treatment of cancer. However, the potential effectiveness of spermidine in cervical cancer has not yet been fully elucidated, and the underlying molecular mechanism involved remains unknown.

The purpose of this study was to demonstrate the potential roles and molecular mechanisms underlying the effects of spermidine in cervical cancer. For this reason, we assessed its function in HeLa cells and found that spermidine strongly suppressed proliferation and induced apoptosis in HeLa cells. Additional mechanistic studies suggested that activation of autophagy mediated the inhibition of cellular proliferation by spermidine and spermidine-induced apoptosis in HeLa cells. Collectively, our results revealed the potent effects of spermidine in the treatment of cervical cancer and provided experimental evidence about the details of the underlying mechanisms.

Materials and methods <sec> <title>Reagents and cell culture

Spermidine was dissolved in dimethylsulfoxide (DMSO; both from Sigma-Aldrich; Merck KGaA, St. Louis, MO, USA). 3-Methyladenine (Sigma-Aldrich; Merck KGaA), an autophagy inhibitor, was used at a concentration of 4 mM in DMSO.

The human cervical cancer cell lines HeLa (HPV-18-infected cervical cancer cells), SiHa (HPV-16-infected cervical cancer cells), and C-33A (HPV-negative cervical cancer cells) were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). Cells were grown in DMEM (GIBCO; Thermo Fisher Scientific, Inc., Waltham, MA, USA), supplemented with 10% fetal bovine serum (Beyotime Institute of Biotechnology, Haimen, China) and 100 U/ml streptomycin/penicillin at 37°C in a humidified atmosphere containing 5% CO₂ in compressed air. When 80–90% confluence was reached, HeLa cells were digested with 0.25% trypsin (Beyotime Institute of Biotechnology) for subsequent experiments.

Cell proliferation assay

Cell viability with spermidine treatment was evaluated using CCK-8 colorimetric assay (Beyotime Institute of Biotechnology) (17). Briefly, cells were seeded in 96-well plates at a density of 2×10⁴ cells/well, at 37°C with 5% CO₂. After culturing cells to 80% confluence, the cells were exposed to varying concentrations of spermidine for 24, 48 or 72 h. CCK-8 was then added to each well followed by incubation, and the absorbance was assessed at 450 nm using a microplate reader (BioTek Instruments, Inc., Winooski, VT, USA). Cell viability was calculated using the following formula: Cell viability (%) = (OD treatment - OD blank)/(OD control - OD blank).

Quantitative real-time PCR (qRT-PCR) assay

HeLa cells were cultured with spermidine at 60, 120 and 180 µM for 24 h, respectively. The control cells were treated with 0.1% DMSO. Following spermidine incubation, the mRNA from HeLa cells was extracted (MagnaPure LC RNA Isolation Kit) and underwent reverse transcription into cDNA according to the Transcription High Fidelity cDNA Synthesis kit (both from Roche Applied Science, Penzberg, Germany), following the corresponding manufacturer's instructions. The expression levels were evaluated using a two-step qRT-PCR kit with SYBR^®-Green (Takara Biotechnology Co., Ltd., Dalian, China) with a final volume of 20 µl (10 µl SYBR^®-Green qPCR Mixture, 10 µM forward and reverse primers) on a 7500 Real-time PCR System (ABI). The threshold cycle values (Ct values) of the genes and internal control genes for the different samples were evaluated. The primer pairs are listed in Table I.

Cell cycle assay

HeLa cells in each group were trypsinized and fixed with 70% ethanol at 4°C for 12 h. Subsequent to washing with phosphate-buffered saline (pH 7.4), the cell cycle analysis was carried out with a Cell Cycle Detection kit (cat. no. C1052; Beyotime Institute of Biotechnology), according to the manufacturer's protocol. The kit contained binding buffer, propidium iodide (PI) staining buffer (20X), and RNase A (50X). In brief, the cells were stained in 500 µl of binding buffer containing 25 µl of PI staining buffer with 10 µl of RNase A for 30 min at 37°C in the dark. Cell cycle kinetics were detected with flow cytometry (FACSCalibur; BD Biosciences, Franklin Lakes, NJ, USA). Results are expressed as the percentage of cells at each phase of the cell cycle.

Cell apoptosis assay

Cellular apoptosis was detected using the Annexin V-FITC/PI Apoptosis Detection Kit (MultiSciences Biotech Co., Ltd. Hangzhou, China). Briefly, after treatment with spermidine, HeLa cells were collected and washed twice with PBS. Cells at 5×10⁵ cells/ml were re-suspended in 400 µl of binding buffer with 5 µl of Annexin V-FITC and 1 µl of PI in the dark. After incubation for 15 min, cell apoptosis was assessed by flow cytometry (FACSCalibur; BD Biosciences, Franklin Lakes, NJ, USA).

Western blot analysis

HeLa cells were lysed with RIPA lysate to extract total protein, and concentration was assessed by a bicinchoninic acid (BCA) protein assay kit (both from Beyotime Institute of Biotechnology). The same amounts of proteins were separated in 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to polyvinylidene fluoride (PVDF) membranes (EMD Millipore, Bedford, MA, USA). Then, 5% skim milk was used to block proteins for 1 h. Subsequently, the blots were detected with specific primary antibodies against GAPDH (cat. no. AF1186), BAX (cat. no. AB026), Bcl-2 (cat. no. AB112), cleaved-caspase-3 (cat. no. AC033), (all 1:1,000; Beyotime Institute of Biotechnology), LC3B (cat. no. 3868S), Atg5 (cat. no. 2630S), Beclin 1 (cat. no. 3738S) (all 1:1,000; Cell Signaling Technology, Danvers, MA, USA) at 4°C incubation overnight. Then, the primary antibodies were washed away, and incubated with corresponding secondary antibodies [cat. no. A0208 (HRP-labeled goat anti-rabbit IgG (H+L) and cat. no. A0216 (HRP-labeled goat anti-mouse IgG (H+L)] (1:5,000; Beyotime Institute of Biotechnology) for 1 h at room temperature. The enhanced chemiluminescence (ECL) solution (Qihai Biotec, Shanghai, China) was used to detect the target bands, and Gel-Pro-Analyzer software (Media Cybernetics, Inc., Rockville, MD, USA) was employed to analyze the gray values of the band. GAPDH served as a loading control.

Statistical analysis

Statistical analysis was performed using GraphPad Prism v. 5.0 software (GraphPad Software, Inc., La Jolla, CA, USA). Data are expressed as the means ± standard deviation (SD). All data presented represent results from at least 3 independent experiments. One-way analysis of variance (ANOVA) followed by the Tukey's multiple comparison test was used to compare differences between groups. Statistical significance was defined as P<0.05.

Results <sec> <title>Spermidine reduces the proliferation of human cervical cancer cell lines

To study the effects of spermidine on the growth of human cervical cancer cell lines, we first performed CCK-8 analysis. The cells were treated with spermidine at different concentrations (0 to 200 µM) for 24 h, and then cell viability was assessed using CCK-8 assays. As shown in Fig. 1A, spermidine significantly inhibited the viability of HeLa cells in a dose-dependent manner. The IC₅₀ values of spermidine for HeLa cells was 121.3 µM (Fig. 1A). Spermidine also significantly reduced the growth of HeLa cells in a time-dependent manner (for 24, 48 and 72 h) (Fig. 1B). To further confirm the inhibition of spermidine specifically in human cervical cancer cells, other human cervical cancer cell lines, including SiHa (HPV-16-infected cervical cancer cells) and C-33A (HPV-negative cervical cancer cells) were tested. Notably, spermidine inhibited the growth of both SiHa (Fig. 1C) and C-33A cell lines in a dose-dependent manner (Fig. 1D). We found that HeLa, SiHa and C-33A cell lines were all sensitive to spermidine-induced cytotoxicity. Collectively, these data revealed that spermidine reduced the viability of human cervical cancer cell lines.

Spermidine affects the mRNA levels of the polyamine biosynthesis pathway of HeLa cells

It has been well established that an increase in intracellular polyamine concentration is correlated with increased cell proliferation as well as tumorigenesis (18,19). Depletion of the intracellular polyamine pools using either a polyamine synthesis inhibitor or a polyamine analog invariably inhibits cell growth in various cancers (20–22). To confirm whether exogenous spermidine inhibited the accumulation of endogenous polyamines, we performed qRT-PCR to detect the messenger RNA (mRNA) expression levels of principal genes in the polyamine biosynthesis pathway. The results revealed that the mRNA level of ornithine decarboxylase (ODC1), spermidine synthase (SRM) and spermine oxidase (SMOX) were significantly decreased in HeLa cells after spermidine treatment (Fig. 2A-C), while the mRNA levels of spermidine/spermine N1-acetyltransferase (SSAT) and spermine synthase (SMS) were significantly increased in HeLa cells after spermidine treatment (Fig. 2D and E). Collectively, these results revealed that exogenous spermidine inhibited the accumulation of endogenous polyamines.

Spermidine inhibits the viability of HeLa cells by arresting the cell cycle at the S phase

To further determine whether the viability of HeLa cells treated with spermidine was decreased, which was due to the reduction of cellular proliferation, we next investigated the effects of spermidine on cell cycle distribution. As shown in Fig. 3A-D, when cells were treated with 120 or 180 µM spermidine, the percentage of HeLa cells in the S phase was significantly increased from 23.78±0.75 to 37.42±1.49 and 38.65±1.05%, compared with the control group, respectively. In addition, the proportion of cells in the G2 phase was not altered (Fig. 3D). These results revealed that spermidine inhibited the proliferation of HeLa cells by arresting the cell cycle at the S phase.

Spermidine induces apoptosis of HeLa cells through the mitochondrial apoptotic pathway

To confirm whether spermidine inhibition of HeLa cell proliferation was caused by apoptosis, we used the Annexin V/PI Cell Apoptosis kit to detect the apoptotic effect of spermidine on HeLa cells by flow cytometric assays. We found that 120 and 180 µM of spermidine treatment significantly increased the apoptosis of HeLa cells compared with the control cells (Fig. 4A-D). To further investigate the promotion of apoptosis of HeLa cells by spermidine, western blot analysis revealed that the expression of Bcl-2 (an anti-apoptotic protein) in HeLa cells was significantly decreased after spermidine treatment (Fig. 5B and E); conversely, the expression of pro-apoptotic proteins cleaved-caspase-3 and BAX protein were significantly increased after spermidine treatment (Fig. 5A, C and D), compared with the controls. Collectively, these results strongly demonstrated that spermidine induced apoptosis of HeLa cells by triggering the mitochondrial apoptotic pathway.

Spermidine induces autophagy of HeLa cells

LC3 acts as a marker of the autophagosome membrane, and is involved in the formation of the autophagic body, and LC3-I/II conversion reflects the number of autophagosomes (23). Beclin 1 is a specific gene associated with autophagy in mammals, which is associated with phospholipid inositol triphosphate-kinase (PI3K), and participates in the formation of autophagosomes (24). Atg5 is a central regulator necessary for autophagy in terms of its involvement in autophagosome elongation (25). Notably, as shown in Fig. 6, western blotting results revealed that LC3 II/LC3 I, Atg5 and Beclin 1 protein levels were significantly increased by spermidine treatment in HeLa cells. These results revealed that spermidine induced autophagy in HeLa cells.

Autophagy mediates the spermidine-induced effects in HeLa cells

To uncover a relationship between apoptosis and autophagy, we used a specific drug inhibitor (3-MA) to block autophagy and analyzed the spermidine-induced effect on HeLa cells. As shown in Fig. 7A, western blots indeed revealed that 3-MA (a specific inhibitor of autophagy) blocked the increase induced by treatment with spermidine in LC3 II/LC3 I, Beclin 1, Atg5, and BAX in HeLa cells (Fig. 7A and C-F), and also blocked the decrease induced by treatment with spermidine in Bcl-2 in HeLa cells (Fig. 7A and B). Moreover, 3-MA significantly blocked the spermidine-induced apoptosis (Fig. 8A-E) and spermidine-inhibited proliferation (Fig. 8F) in HeLa cells. These results provide additional evidence that autophagy mediates spermidine-induced inhibition of cellular proliferation and promotion of apoptosis in HeLa cells.

Discussion

Primary polyamines, putrescine, spermidine and spermine are involved in cellular proliferation, differentiation, tissue development, and carcinogenesis by maintaining chromatin structure, membrane stability and regulating ion channels (14,26). Since 1971, when spermidine was found to be markedly elevated in the urine of many cancer patients (27), there have been attempts to use the biosynthetic pathway of polyamines as therapeutic targets or to use levels of polyamines as prognostic markers for cancer patients. Polyamine depletion has been suggested for cancer prevention, but α-difluoromethylornithine (DFMO) was not clinically effective neither alone nor in combination with other agents (28). Depletion of polyamines by spermidine/spermine N1-acetyltransferase (SSAT) significantly inhibited cellular proliferation, migration, and invasion through the AKT/GSK3β/β-catenin signaling pathway in hepatocellular carcinoma and colorectal cancer cells (29). However, previous studies reported that inhibition of spermidine production promoted colorectal cancer growth (15), and that exogenous spermidine suppressed hepatocellular carcinomas in mice (16). Also, spermidine can alter protein acetylation patterns to regulate autophagy and promote longevity in multiple model systems (30,31). Therefore, the precise biochemical function of spermidine in cancer requires clarification.

In the present study, we chose to assess the effects of spermidine on HeLa cells. Previous studies have revealed that overexpressed SRM (spermidine synthase) in colorectal cancer cell lines CT-26 or MC-38 largely increased spermidine production; consequently, CT-26- or MC-38-inoculated tumors were inhibited (15). Consistent with these studies, our results demonstrated that spermidine inhibited the proliferation of cervical cancer cells in a dose-dependent manner (Fig. 1). However, we found that the mRNA level of ODC1, SRM and SMOX were significantly decreased, while the mRNA levels of SSAT and SMS were significantly increased in HeLa cells after spermidine treatment (Fig. 2). It suggested that exogenous spermidine inhibited the synthesis of putrescine and spermidine, and promoted the spermine and spermidine consumption. Depletion of the intracellular polyamines inhibits cell growth in HeLa cells. In addition, we found a significant increase in the number of cells at the S phase (Fig. 3D), suggesting that spermidine inhibited the proliferation of HeLa cells by arresting the cell cycle at the S phase.

Previous studies have shown that excessive polyamine accumulation induces cellular apoptosis in ornithine decarboxylase-overproducing L1210 cells (32). Consistent with these studies, we also found that spermidine significantly induced apoptosis of HeLa cells based upon flow cytometric analysis of Annexin V-FITC/PI-stained cells (Fig. 4). BAX migrates to the mitochondrial membrane and inhibits the action of Bcl-2, causing damage to the mitochondrial membrane; this in turn releases cytochrome c and leads to apoptosis via the activation of caspase-3 and caspase-7 (33). In our study, western blot analysis indicated that spermidine treatment resulted in attenuated expression of Bcl-2 and increased expression of BAX and cleaved caspase-3 levels in HeLa cells (Fig. 5). Thus, these results support the concept that the enhanced apoptosis of HeLa cells treated with spermidine is due to the activation of mitochondrial apoptotic pathways.

Autophagy is another cellular degradative pathway that is essential for organismal homeostasis, and it has been implicated in protecting organisms from cancer (34,35). Previous studies have revealed that exogenous spermidine suppresses hepatocellular carcinoma in mice by activating MAP1S-mediated autophagy (15). Glaucocalyxin inhibited the proliferation of human cervical cancer cells in vitro through the induction of autophagy by the phosphatidylinositol-4,5-bisphosphate 3-kinase/Akt signaling pathway (13). The natural agent HMDB exerted antitumor effects on human cervical cancer cells by induction of autophagy followed by increased expression of LC3 II/LC3 I and Beclin 1 (36). Resveratrol-induced cell death in OVCAR-3 human ovarian cancer cells occured via induced autophagy followed by increased Atg5 expression and promotion of LC3 cleavage (37). Consistent with these studies, we also found that spermidine treatment resulted in increased LC3 II/LC3 I, Atg 5, and Beclin 1 protein levels in HeLa cells (Fig. 6). These results revealed that spermidine inhibited the proliferation of HeLa cells by activating autophagy.

Previous evidence has suggested the existence of crosstalk between the apoptotic and autophagic signaling pathways (38,39). Activation of ROS production simultaneously induced both autophagy and apoptosis in cancer cells (40). Autophagy itself can induce cell death, a process known as autophagic cell death (41). Resveratrol promoted autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation (42). Beclin 1 is an essential autophagic effector that plays important roles in crosstalk with the apoptotic pathway, interacting with antiapoptotic Bcl-2 proteins (6). Notably, knockdown of Beclin 1 promoted cell growth and inhibited apoptosis in the A549 human lung cancer cell line (43). Atg5 functions as a switch, shifting the process of cell death from autophagy to apoptosis. Pre-treatment with 3-methyladenine or Atg5-shRNA attenuated justicidin A-induced LC3-II expression and LC3 puncta formation and blocked justicidin A-induced suppression in cell growth via inhibition of apoptosis (44). The present study indicates that spermidine inhibits HeLa cells through both apoptosis and autophagy. We found that the autophagy inhibitor 3-MA attenuated the levels of LC3 II/LC3 I, Atg 5, Beclin 1 and BAX, and enhanced the level of Bcl-2 in HeLa cells treated with spermidine (Fig. 7), and blocked spermidine-induced apoptosis and the spermidine-inhibited proliferation of HeLa cells (Fig. 8). These results strongly demonstrated that autophagy mediates the effects of spermidine on HeLa cells.

In summary, we herein demonstrated that spermidine suppressed proliferation and promoted apoptosis of HeLa cells, and that these effects were mediated by autophagic activation. In our study, the results indicated novel effects of spermidine with respect to its potential use in cervical cancer therapy and provided aspects of the details of the underlying mechanisms of action, focusing on the crosstalk between apoptosis and autophagy.

Acknowledgements

Not applicable.

Funding

The present study was supported in part by a grant from the National Natural Science Foundation of China (21503190), the Education Foundation of Zhejiang province (Y201636954), the Zhejiang Medical College Youth Dr. start-up funding (2015B07), the Foundation of Zhejiang province Chinese Medicine, Science and Technology (2017ZB030), and Medical and Health Science and Technology Project of Zhejiang Province (2018277310).

Availability of data and materials

The datasets used during the present study are available from the corresponding author upon reasonable request.

Authors' contributions

YC and XW conceived and designed the study. YC, HZ, XC and ZS performed the experiments. YC and XW wrote the paper. YC, XW and HZ reviewed and edited the manuscript. All authors read and approved the manuscript and agree to be accountable for all aspects of the research in ensuring that the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References 1

Schiffman

Wentzensen

Wacholder

Kinney

Gage

Castle

Human papillomavirus testing in the prevention of cervical cancer

J Natl Cancer Ins1033683832011

10.1093/jnci/djq562

Ferlay

Soerjomataram

Dikshit

Eser

Mathers

Rebelo

Parkin

Forman

Bray

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Int J Cancer136E359E3862015

10.1002/ijc.29210

25220842

Uyar

Rader

Genomics of cervical cancer and the role of human papillomavirus pathobiology

Clin Chem601441462014

10.1373/clinchem.2013.212985

24046199

Malfetano

Concurrent Cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer-NEJM

New Eng J Med340114411531999

10.1056/NEJM199904153401502

10202165

Wieringa

van der Zee

de Vries

van Vugt

Breaking the DNA damage response to improve cervical cancer treatment

Cancer Trea Rev4230402016

10.1016/j.ctrv.2015.11.008

Mei

Sinha

Role of the Crosstalk between Autophagy and Apoptosis in Cancer

J Oncol20131027352013

10.1155/2013/102735

23840208

3687500

Ashkenazi

Targeting the extrinsic apoptosis pathway in cancer

Cytokine Growth Factor Rev193253312008

10.1016/j.cytogfr.2008.04.001

18495520

Cotter

Apoptosis and cancer: The genesis of a research field

Nat Rev Cancer95015072009

10.1038/nrc2663

19550425

Karantza

White

Role of autophagy in breast cancer

Autophagy36106131900

10.4161/auto.4867

Jin

White

Role of autophagy in cancer: Management of metabolic stress

Autophagy328312007

10.4161/auto.3269

16969128

2770734

Tsujimoto

Shimizu

Another way to die: autophagic programmed cell death

Cell Death Differ12Suppl 2S1528S15342005

10.1038/sj.cdd.4401777

Yang

Wang

LIANG

SONG

Fucoidan induce apoptosis of HeLa cells accompanied by the induction of autophagy

Lat Am J Pharm36112611332017

Pan

Bai

Shen

Sun

Glaucocalyxin B induces apoptosis and autophagy in human cervical cancer cells

Mol Med Rep14175117552016

10.3892/mmr.2016.5450

27356884

Battaglia

De Stefano Shields

Murray-Stewart

Casero

Polyamine catabolism in carcinogenesis: Potential targets for chemotherapy and chemoprevention

Amino Acids465115192014

10.1007/s00726-013-1529-6

23771789

3795954

Miao

Peng

Zhang

Chen

Hao

Xie

Wang

Pang

Ruan

Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM

Nat Commun7117162016

10.1038/ncomms11716

27189574

4873969

Yue

Zou

Jiang

Huang

Liu

Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma by activating MAP1S-mediated autophagy

Cancer Res77293829512017

10.1158/0008-5472.CAN-16-3462

28386016

5489339

Zhang

Pan

Dorfman

Chen

Liu

Zhou

Huang

Zhang

Yang

Liu

AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition

Oncotarget722285222942016

26993777

5007137

Durie

Salmon

Russell

Polyamines as markers of response and disease activity in cancer chemotherapy

Cancer Res372142211977

830407

Soda

The mechanisms by which polyamines accelerate tumor spread

J Exp Clin Cancer Res30952011

10.1186/1756-9966-30-95

21988863

3206444

Thomas

John

Hsu

Yang

Keinänen

Hyvönen

Tamoxifen metabolite endoxifen interferes with the polyamine pathway in breast cancer

Amino Acids48229323022016

10.1007/s00726-016-2300-6

27438264

Nowotarski

Woster

Casero

Polyamines and cancer: Implications for chemotherapy and chemoprevention

Expert Rev Mol Med15e32013

10.1017/erm.2013.3

23432971

4027058

Cameron

Wallace

Decreased sensitivity to aspirin is associated with altered polyamine metabolism in human prostate cancer cells

Amino Acids48100310122016

10.1007/s00726-015-2143-6

26704566

4796368

Shi

Cao

Shikonin promotes autophagy in BXPC-3 human pancreatic cancer cells through the PI3K/Akt signaling pathway

Oncol Lett8108710892014

10.3892/ol.2014.2293

25120662

4114587

Wang

Chou

Lin

Zoledronic acid induces apoptosis and autophagy in cervical cancer cells

Tumour Biol3511913119202014

10.1007/s13277-014-2460-5

25142231

Klionsky

Autophagy: From phenomenology to molecular understanding in less than a decade

Nat Rev Mol Cell Biol89319372007

10.1038/nrm2245

17712358

Gerner

Meyskens

Polyamines and cancer: Old molecules, new understanding

Nat Rev Cancer47817922004

10.1038/nrc1454

15510159

Russell

Increased polyamine concentrations in the urine of human cancer patients

Nat New Biol2331441451971

10.1038/newbio233144a0

5286749

Miller-Fleming

Olin-Sandoval

Campbell

Ralser

Remaining mysteries of molecular biology: the role of polyamines in the cell

J Mol Biol427338934062015

10.1016/j.jmb.2015.06.020

26156863

Wang

Ruan

Zhao

Wang

Liu

Wang

Hou

Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells

Oncotarget8109211092017

27901475

5352037

Morselli

Mariño

Bennetzen

Eisenberg

Megalou

Schroeder

Cabrera

Bénit

Rustin

Criollo

Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome

J Cell Biol1926156292011

10.1083/jcb.201008167

21339330

3044119

Eisenberg

Abdellatif

Schroeder

Primessnig

Stekovic

Pendl

Harger

Schipke

Zimmermann

Schmidt

Cardioprotection and lifespan extension by the natural polyamine spermidine

Nat Med22142814382016

10.1038/nm.4222

27841876

5806691

Poulin

Pelletier

Pegg

Induction of apoptosis by excessive polyamine accumulation in ornithine decarboxylase-overproducing L1210 cells

Biochem J3117237271995

10.1042/bj3110723

7487924

1136062

Kumar

Eroglu

Stokes

IIIScissum-Gunn

Saldanha

Singh

Manne

Ponnazhagan

Mishra

Resveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells

Oncotarget820895209082017

10.18632/oncotarget.14947

28157696

5400554

Levine

Unraveling the role of autophagy in cancer

Autophagy265662006

10.4161/auto.2.2.2457

16874090

Liu

Ryan

Autophagy and cancer-issues we need to digest

J Cell Sci125234923582012

10.1242/jcs.093708

22641689

Tsai

Hsu

Huang

Lin

Pan

Hong

Chen

1-(2-Hydroxy-5-methylphenyl)-3-phenyl-1, 3-propanedione Induces G1 cell cycle arrest and autophagy in HeLa cervical cancer cells

Int J Mol Sci17E12742016

10.3390/ijms17081274

27527160

5000672

Lang

Qin

Zhang

Fang

Hao

Apoptotic cell death induced by resveratrol is partially mediated by the autophagy pathway in human ovarian cancer cells

PLoS One10e01291962015

10.1371/journal.pone.0129196

26067645

4466135

Hou

Han

Goldstein

Rabinowich

Autophagic degradation of active caspase-8: A crosstalk mechanism between autophagy and apoptosis

Autophagy68919002010

10.4161/auto.6.7.13038

20724831

3039736

Hui

Crowe

Yang

Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer

J Cancer Res Clin Oncol141671892015

10.1007/s00432-014-1803-3

25146530

Wong

Iskandar

Yadav

Hirpara

Loh

Pervaiz

Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation

PLoS One5e99962010

10.1371/journal.pone.0009996

20368806

2848860

Lamy

Ngo

Emre

Shaffer

IIIYang

Tian

Nair

Kruhlak

Zingone

Landgren

Staudt

Control of autophagic cell death by caspase-10 in multiple myeloma

Cancer Cell234354492013

10.1016/j.ccr.2013.02.017

23541952

4059832

Puissant

Robert

Fenouille

Luciano

Cassuto

Raynaud

Auberger

Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation

Cancer Res70104210522010

10.1158/0008-5472.CAN-09-3537

20103647

Wang

Fan

Zhou

Duan

Zhao

Knockdown of autophagy-related gene BECLIN1 promotes cell growth and inhibits apoptosis in the A549 human lung cancer cell line

Mol Med Rep7150115052013

10.3892/mmr.2013.1379

23525201

Won

Yen

Liu

Lan

Jiang-Shieh

Lin

Justicidin A-induced autophagy flux enhances apoptosis of human colorectal cancer cells via class III PI3K and Atg5 pathway

J Cell Physiol2309309462015

10.1002/jcp.24825

25216025

Figure 1.

Spermidine inhibits the proliferation of HeLa, SiHa, C-33A cell lines. (A) HeLa cells were cultured with an ascending concentration range of spermidine (from 0 to 200 µM) for 24 h and cell viability was detected by CCK-8 assay (n=6). Effects on cell viability were expressed as a function of µM drug concentration (log scale). Corresponding IC₅₀ values were calculated with the appropriate software (GraphPad Prism). (B) HeLa cells were cultured with spermidine at 60, 120 or 180 µM, for 24, 48 and 72 h, respectively (n=6). (C) Spermidine treatment at 60, 120 and 180 µM in SiHa cells after 24 h was performed and cell viability was assessed by CCK-8 assays, respectively (n=6). (D) Spermidine treatment at 60, 120, 180 µM in C-33A cells after 24 h was performed and cell viability was assessed by CCK-8 assays, respectively (n=6). Data are the means ± SD. *P<0.05, **P<0.01, compared with the control. The controls were treated with 0.1% DMSO.

Figure 2.

Spermidine affects the principal genes in the polyamine biosynthesis pathway of HeLa cells. (A-E) qRT-PCR detected ODC1, SRM, SMOX, SSAT and SMS mRNA expression levels and the relative expression was assessed by quantitative analysis. Data are expressed as the means ± standard deviation. **P<0.01, compared with the control. The controls were treated with 0.1% DMSO. ODC1, ornithine decarboxylase; SRM, spermidine synthase; SMOX, spermine oxidase; SSAT, spermidine/spermine N1-acetyltransferase; SMS, spermine synthase.

Figure 3.

Spermidine reduces the viability of HeLa cells by arresting the cell cycle at the S phase. (A-C) Cell cycle distribution of HeLa cells was analyzed by flow cytometry, in cells treated with (A) the control, (B) 120 µM spermidine, or (C) 180 µM spermidine. (D) The percentage of cell cycle distribution of HeLa cells under various conditions (n=3) was represented by a column diagram. Data are expressed as the means ± SD. **P<0.01, compared with control. The controls were treated with 0.1% DMSO.

Figure 4.

Spermidine induces apoptosis in HeLa cells. (A-C) Flow cytometric analysis of Annexin V-FITC/PI-stained HeLa cells treated with (A) the control (0.1% DMSO, (B) 120 µM spermidine, or (C) 180 µM spermidine. Cells were characterized as healthy cells (bottom left quadrant), necrotic (top left quadrant), early apoptotic (bottom right quadrant), or late apoptotic (top right quadrant). (D) Quantitative analysis of the apoptotic rates for HeLa cells under various concentrations of spermidine as displayed in A-C (n=3). Data are expressed as the means ± SD. **P<0.01, compared with the controls. The controls were treated with 0.1% DMSO.

Figure 5.

Spermidine affects the expression of c-caspase-3, BAX, and Bcl-2 in HeLa cells. (A-B) Western blot analysis detected the proteins of apoptosis, c-caspase-3, BAX, and Bcl-2 in cells treated with spermidine. (C-E) Quantitative analysis of the relative expression of (C) c-caspase-3, (D) BAX and (E) Bcl-2 as displayed in A and B (n=3). Data are expressed as the means ± SD. **P<0.01, compared with the controls. The controls were treated with 0.1% DMSO.

Figure 6.

Spermidine affects the expression of LC3 II/LC3 I, Beclin 1, and Atg5 in HeLa cells. (A) Western blotting detected the proteins of autophagy, LC3 II/LC3 I, Beclin 1, and Atg5, in cells treated with spermidine. (B-D) Quantitative analysis of the relative expression of (B) LC3 II/LC3 I, (C) Beclin 1 and (D) Atg5 as displayed in A. (n=3). Data are expressed as the means ± SD. **P<0.01, compared with the controls. The controls were treated with 0.1% DMSO.

Figure 7.

The autophagy inhibitor 3-MA blocks the effects of spermidine in HeLa cells. (A) Western blotting detected LC3 II/LC3 I, Beclin 1, Atg5, BAX, and Bcl-2 in HeLa cells treated with the control, spermidine (120 µM), and/or 3-MA (4 mM). GAPDH was used as the internal control. (B-F) Quantitative analysis of the relative protein expression for (B) Bcl-2, (C) BAX, (D) LC3 II/LC3 I, (E) Beclin 1, and (F) Atg5 as displayed in A (n=3). Data are expressed as the means ± SD. **P<0.01, compared with the controls. ^##P<0.01, compared with spermidine treatment. The controls were treated with 0.1% DMSO.

Figure 8.

The autophagy inhibitor 3-MA blocks the induction of apoptosis and inhibition of proliferation in HeLa cells with spermidine treatment. (A-D) Flow cytometric analysis of Annexin V-FITC/PI-stained HeLa cells treated with (A) the control medium, (B) 3-MA, (C) spermidine, or (D) spermidine plus 3-MA (n=3). Cells were characterized as healthy cells (bottom left quadrant), necrotic (top left quadrant), early apoptotic (bottom right quadrant), or late apoptotic (top right quadrant). (E) Quantified data regarding the apoptotic rates of HeLa cells as displayed in A-D. (F) CCK-8 assays were performed on HeLa cells after 24 h in control media, or with 3-MA, spermidine, or spermidine plus 3-MA (n=6). Data are expressed as the means ± SD. **P<0.01, compared with the controls. ^##P<0.01, compared with spermidine treatment. Controls were treated with 0.1% DMSO.

Table I.

Primer sequences of ODC1, SRM, SMS, SSAT, SMOX, GAPDH.

Gene	Forward	Reverse
ODC1	CAGCTTTCACGCTTGCAGTT	ATCTTCGTCATCAGAGCCCG
SRM	CCCTCCGTGGAGTCCGTGGTC	CTGGCAGGAACTTCTTGGAGACTTG
SMS	TGGAAATATTCTCATCCTTAGTGGG	CGGGTATATGCCAAATCACTCTCT
SSAT	GGCATAGGATCAGAAATTCTGAAGA	CTGCTACCAAGAAGTGCATGCTG
SMOX	CAATGCTGAAAGTCAAAATAGCGTG	CTCTGGGTCGTCAGGGTC ATTCC
GAPDH	CATCAATGGAAATCCCATCA	GACTCCACGACGTACTCAGC